- Home
- JXN vs CORT Comparison
JXN vs CORT Comparison
Compare JXN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXN
- CORT
- Stock Information
- Founded
- JXN 1961
- CORT 1998
- Country
- JXN United States
- CORT United States
- Employees
- JXN N/A
- CORT N/A
- Industry
- JXN Life Insurance
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- JXN Finance
- CORT Health Care
- Exchange
- JXN Nasdaq
- CORT Nasdaq
- Market Cap
- JXN 6.2B
- CORT 7.1B
- IPO Year
- JXN N/A
- CORT N/A
- Fundamental
- Price
- JXN $83.77
- CORT $112.29
- Analyst Decision
- JXN Hold
- CORT Strong Buy
- Analyst Count
- JXN 5
- CORT 4
- Target Price
- JXN $97.40
- CORT $127.00
- AVG Volume (30 Days)
- JXN 1.3M
- CORT 1.7M
- Earning Date
- JXN 05-07-2025
- CORT 04-30-2025
- Dividend Yield
- JXN 3.85%
- CORT N/A
- EPS Growth
- JXN 9.11
- CORT 30.85
- EPS
- JXN 11.74
- CORT 1.23
- Revenue
- JXN $3,350,000,000.00
- CORT $675,040,000.00
- Revenue This Year
- JXN $116.51
- CORT $36.81
- Revenue Next Year
- JXN $1.32
- CORT $29.94
- P/E Ratio
- JXN $7.08
- CORT $92.86
- Revenue Growth
- JXN 8.66
- CORT 39.94
- 52 Week Low
- JXN $62.81
- CORT $20.84
- 52 Week High
- JXN $115.22
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- JXN 45.30
- CORT 84.76
- Support Level
- JXN $82.43
- CORT $53.79
- Resistance Level
- JXN $90.33
- CORT $61.09
- Average True Range (ATR)
- JXN 3.35
- CORT 3.65
- MACD
- JXN 0.34
- CORT 3.22
- Stochastic Oscillator
- JXN 43.79
- CORT 97.96
About JXN Jackson Financial Inc.
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.